ArticleOphthalmology and therapy2016

Prospective Observational Post-marketing Study of Tafluprost 0.0015%/Timolol 0.5% Combination Ophthalmic Solution for Glaucoma and Ocular Hypertension: Short-Term Efficacy and Safety.

Yasutaka Takagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.